Tag Archives: Merck

Years after Cubist buyout, Merck scores a new Zerbaxa indication. Can it jump-start sales?

Merck hasn’t exactly made a fortune on its $ 9.5 billion Cubist Pharmaceuticals buyout, but now, a next-gen antibiotic it acquired in that deal has a brand-new indication that could help jump-start sales. On Monday, the FDA approved that drug, Zerbaxa, to treat adults with hospital-acquired and ventilator-associated pneumonia. It’s an add-on to Zerbaxa’s original approvals—to treat complicated… Read More »

Merck (NYSE: MRK) details integration plans

by CS Chen Merck & Co., Inc. (NYSE: MRK), one of the largest pharmaceutical companies in the world, which is known for its treatments like Gardasil (human papilloma virus), Propecia (baldness), and Zocor (cholesterol) detailed its global structuring program on Friday. The company’s integration plans aim at its research and development, business operations, and manufacturing. … Read More »